Certainly, it's too early to conclude anything yet. Nobody can predict the future, but if you look at it, from the time that COVID began, they basically had two partners, Ng Biotech and Access Bio, both were previous commercial partners.
Atomo has a good product, that's why I'm still interested in the business, it's just they don't seem to deliver enough, maybe is my expectations.
Well, maybe it could change in the future, anyway, all the best.
Why I think I should not hold AT1 anymore, page-41
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
